Psychometric Evaluation of Quality of Life in a Three-Arm, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-Onset Seizures (EXIST-3)

被引：0
|
作者：
Franz, D.
de Vries, P.
Curatolo, P.
Nabbout, R.
Fan, J.
Neary, M.
Herbst, F.
Sully, K.
Brohan, E.
Lawson, J.
机构：
来源：
ANNALS OF NEUROLOGY | 2017年 / 82卷
关键词：
Epilepsy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
25
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [1] Psychometric Evaluation of Quality of Life in a Three-Arm, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Everolimus as Adjunctive Therapy in Patients with Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-Onset Seizures (EXIST-3)
    Franz, David N.
    de Vries, Petrus J.
    Curatolo, Paolo
    Nabbout, Rima
    Fan, Jenna
    Neary, Maureen
    Herbst, Fabian
    Sully, Kate
    Brohan, Elaine
    Lawson, John
    ANNALS OF NEUROLOGY, 2017, 82 : S159 - S160
  • [2] Psychometric evaluation of quality of life measures in a three-arm, randomized, double-blind, placebo-controlled phase III study of everolimus as adjunctive therapy in patients with tuberous sclerosis complex (TSC) who have refractory partial-onset seizures (EXIST-3)
    de Vries, Petrus
    Franz, David
    Curatolo, Paolo
    Nabbout, Rima
    Berkowitz, Noah
    Neary, Maureen
    Herbst, Fabian
    Sully, Kate
    Brohan, Elaine
    Lawson, John
    NEUROLOGY, 2017, 88
  • [3] TRIAL IN PROGRESS: EXIST-3, A PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF TWO TROUGH RANGES OF EVEROLIMUS AS ADJUNCTIVE THERAPY IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) WHO HAVE REFRACTORY PARTIAL-ONSET SEIZURES (POS)
    French, J.
    Franz, D.
    de Vries, P.
    Nabbout, R.
    Vaury, A.
    Berkowitz, N.
    Lam, D.
    Lawson, J.
    Curatolo, P.
    EPILEPSIA, 2013, 54 : 65 - 65
  • [4] IMPACT OF EVEROLIMUS TREATMENT ON QUALITY OF LIFE (QOL) IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) WHO HAVE REFRACTORY PARTIAL-ONSET SEIZURES IN THE CONTEXT OF AN INTERVENTIONAL CLINICAL TRIAL (EXIST-3)
    Nabbout, R.
    Franz, D. N.
    Lawson, J.
    Curatolo, P.
    Neary, M.
    Fan, J.
    Herbst, F.
    Sully, K.
    Brohan, E.
    de Vries, P. J.
    EPILEPSIA, 2017, 58 : S102 - S103
  • [5] Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
    French, Jacqueline A.
    Lawson, John A.
    Yapici, Zuhal
    Ikeda, Hiroko
    Polster, Tilman
    Nobbout, Rima
    Curatolo, Paolo
    de Vries, Petrus J.
    Diugos, Dennis J.
    Berkowitz, Noah
    Voi, Maurizio
    Peyrard, Severine
    Pelov, Diana
    Franz, David N.
    LANCET, 2016, 388 (10056): : 2153 - 2163
  • [6] A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures
    Biton, Victor
    Krauss, Gregory
    Vasquez-Santana, Blanca
    Bibbiani, Francesco
    Mann, Allison
    Perdomo, Carlos
    Narurkar, Milind
    EPILEPSIA, 2011, 52 (02) : 234 - 242
  • [7] A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures
    Biton, Victor
    Krauss, Gregory
    Bibbiani, Francesco
    Mann, Allison
    Perdomo, Carlos
    Narurkar, Milind
    NEUROLOGY, 2010, 74 (09) : A122 - A122
  • [8] EFFICACY AND SAFETY OF PERAMPANEL AS ADJUNCTIVE THERAPY IN ADOLESCENTS WITH REFRACTORY PARTIAL-ONSET SEIZURES: ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY
    Villanueva, V.
    Rozentals, G.
    Yang, H.
    Squillacote, D.
    Zhu, J.
    Laurenza, A.
    EPILEPSIA, 2011, 52 : 242 - 242
  • [9] Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study
    Karaoglan, Mustafa
    TURKISH JOURNAL OF NEUROLOGY, 2018, 24 (02) : 193 - 194
  • [10] Adjunctive everolimus therapy for the treatment of refractory seizures associated with tuberous sclerosis complex: Results from a randomized, placebo-controlled, phase 3 trial
    French, Jacqueline
    Lawson, John A.
    Yapici, Zuhal
    Polster, Tilman
    Nabbout, Rima
    Curatolo, Paolo
    de Vries, Petrus J.
    Berkowitz, Noah
    Voi, Maurizio
    Peyrard, Severine
    Vaury, Alexandra
    Franz, David
    NEUROLOGY, 2016, 87 (02) : E23 - E24
12345